Biotech

All Articles

Analysts dig into Avidity's DMD win, showing nuances in records

.Avidity Biosciences pleased entrepreneurs with period 1/2 data in Duchenne muscular dystrophy (DMD)...

Actinogen's cortisol blocker fails stage 2 depression research study

.Actinogen Medical's cortisol blocker has missed the primary endpoint of a period 2 study in depress...

Bivictrix determines going exclusive only way to take ADC in to medical clinic

.Antibody-drug conjugates (ADCs) have actually gone to the facility of numerous a billion-dollar bio...

TPG leadings up funds to $580M for assets all over life scientific researches

.Resource manager TPG, which has actually sustained biotechs such as Sionna Therapeutics and also Sa...

Merck quits period 3 TIGIT trial in lung cancer for impossibility

.Merck &amp Co.'s TIGIT program has actually experienced another problem. Months after shuttering a ...

After a challenging year, Exscientia folds right into Recursion

.After a year described by pipeline cuts, the variation of its CEO as well as layoffs, Exscientia wi...

Cullinan, after $25M bargain, return bispecific to Port

.Cullinan Rehab was actually made an impression on good enough with Harbour BioMed's bispecific invu...

A more detailed look at Intense Biotech's Ferocious 15

.Within this week's incident of "The Best Pipe," we are actually diving into Ferocious Biotech's yea...

Lilly encounters period 2 failing of tau-targeting med

.The confetti is actually still flying coming from Eli Lilly's event commemorating the commendation ...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of substantial management hirings, shootings and...